Abdul Mannan: Why Thalassaemia Is More Than Low Haemoglobin
Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, shared a post on LinkedIn:
”Alpha never leaves.
It has been there since your very first embryonic cells. The same chain. Constant. Its partner, though, is where the story begins.
Here is how haemoglobin changes from embryo to adult:
- Very early embryo: zeta joins epsilon to form Hb Gower one.
- Fetal life: alpha joins gamma to form HbF, the dominant haemoglobin before birth.
- Late fetal life and birth: gamma gradually decreases while beta increases, so HbA begins to appear.
- Adult life: about ninety six to ninety eight percent HbA, up to three percent HbA2, and only a very small amount of HbF remains.
The beta-like chain is the real shape shifter.
Epsilon becomes gamma, gamma becomes beta, and a small amount becomes delta.
Each transition is tightly controlled by development, not random chance.
And this is the part that changes how you think about thalassaemia.
The problem is not only low haemoglobin. The real problem is chain imbalance.
When beta chains are reduced, extra alpha chains are left unmatched. They precipitate inside the cell, damage the membrane, and shorten red cell survival. That is the disease mechanism.
It also explains why HbF reactivation works.
Hydroxyurea and newer gene therapies do not simply increase haemoglobin numbers. They bring gamma chains back and partially reverse the developmental switch toward adult haemoglobin.
Adult haemoglobin fractions adapted from Rosove, 2024.
What is the biggest misconception your trainees have about haemoglobin switching?”

Other posts from Abdul Mannan on Hemostasis Today.
-
Aug 23, 2026, 17:51Gurpreet Kaurr: A Proud Milestone in Haematology and Oncology
-
Aug 23, 2026, 17:33Kathrine Kaspersen: How Voluntary Plasma Donors Helped Transform Denmark’s Plasma Supply
-
Aug 23, 2026, 16:51Sthanu Subramanian: Empagliflozin and a Rise in Hematocrit
-
Aug 23, 2026, 16:50Lale Tokgözoğlu: New PCSK9i Research Published in the European Heart Journal
-
Aug 23, 2026, 16:44Eric Gehrie: Your 2026 Guide to the Essentials of Transfusion Medicine
-
Aug 23, 2026, 16:35Thomas Dayspring: The Overlooked Pathway in Cholesterol Homeostasis
-
Aug 23, 2026, 16:28Evan Mapelu: The People Who Make Cancer Care Meaningful
-
Aug 23, 2026, 16:09Felice Gragnano: New Publication on Aspirin Discontinuation After PCI for Acute Coronary Syndromes
-
Aug 23, 2026, 16:06Mostafa Faisal: Donor Type and Long-Term Quality of Life After HCT for Severe Aplastic Anemia